Horizon Europe: Health

Development of new effective therapies for rare diseases

Deadline: 1 februari 2022

Less than 6% of rare diseases have an approved treatment option. By approaching rare diseases with commonalities like shared biological features proposals should address multiple rare diseases and not a single disease.

Proposals for this call should contribute to at least one of the following outcomes:

  • Researchers make better use of new knowledge
  • Researchers use robust preclinical technologies to increase the successful development of new therapies for rare diseases.
  • Regulators can approve therapies for rare diseases faster due to more successful late-stage interventions tested.
  • People living with rare disease get access to new therapies or medical products

Call ID: HORIZON-HLTH-2022-DISEASE-06-04-two-stage

Stöder projekt inom:

Officiell utlysning från Horizon Europe: Health

Begär kontakt angående finansiering från Horizon Europe: Health

Låt oss ha en informell diskussion om era möjligheter för att ansöka om detta utlysning inom Horizon Europe: Health.

Alle utlysningar från Horizon Europe: Health

Om Horizon Europe: Health

The Horizon Europe: Health Cluster supports research and innovation that contribute to Europe’s recovery and resilience from the global pandemic as well as projects aimed at the cancer care pathway. There are six specific areas of impact contained in the Health Cluster:

  • Staying healthy in a rapidly changing society
  • Living and working in a health-promoting environment
  • Tackling diseases and reducing disease burden
  • Ensuring access to innovative, sustainable and high-quality health care
  • Unlocking the full potential of new tools, technologies and digital solutions for a healthy society
  • Maintaining an innovative, sustainable and globally competitive health-related industry
Mer om bidragsprogram